


Healthcare News Roundup: Licensing
HSMN NewsFeed - 17 Apr 2012
Abbott Licenses Biomarkers for Use in Differentiating Aggressive from Nonaggressive Prostate Cancer
Abbott Licenses Biomarkers for Use in Differentiating Aggressive from Nonaggressive Prostate Cancer
HSMN NewsFeed - 14 Mar 2012
FDA Approves BINOSTO(TM), First and Only Effervescent Osteoporosis Treatment in a Buffered Solution
FDA Approves BINOSTO(TM), First and Only Effervescent Osteoporosis Treatment in a Buffered Solution
